$2.78
0.031.09%
After Hours: 9:27 AM EDT
15 minutes delayed
Comments
Loading...
AbCellera Biologics (ABCL) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAbCellera Biologics (NASDAQ:ABCL) Stock Quotes, Forecast and News Summary
AbCellera Biologics Stock (NASDAQ: ABCL) stock price, news, charts, stock research, profile.
| Open | $2.81 |
| Close | - |
| Volume / Avg. | 1.38M / 1.90M |
| Day Range | $2.73 - $2.86 |
| 52 Wk Range | 2.34 - 6.06 |
| Market Cap | $819.17M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 54 |
| Short Interest | 7.74% |
| Days to Cover | 8.2 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About AbCellera Biologics Inc
Sector
Health Care
Industry
Life Sciences Tools & Services
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy AbCellera Biologics (ABCL) stock?
You can purchase shares of AbCellera Biologics (NASDAQ:ABCL) through any online brokerage.
Who are AbCellera Biologics (ABCL) competitors?
Other companies in AbCellera Biologics’s space includes: 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS), Sotera Health (NASDAQ:SHC), Quanterix (NASDAQ:QTRX) and ChromaDex (NASDAQ:CDXC).
What is the forecast, or price target, for AbCellera Biologics (ABCL) stock?
AbCellera Biologics has a consensus price target of $21.67.
What is the current price for AbCellera Biologics (ABCL)?
The stock price for AbCellera Biologics (NASDAQ: ABCL) is $2.745 last updated September 19, 2024 at 3:55 PM EDT.
Does AbCellera Biologics (ABCL) pay a dividend?
There are no upcoming dividends for AbCellera Biologics.
When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?
AbCellera Biologics’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is AbCellera Biologics (ABCL) going to split?
There is no upcoming split for AbCellera Biologics.
What sector and industry does AbCellera Biologics (ABCL) operate in?
AbCellera Biologics is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.